A Systematic Review of Cutaneous Hypopigmentation Disorder Associated with Neurologic Involvement
Authors:
- Piero PavonePiero Pavone
- Xena Giada PappalardoXPXena Giada Pappalardo
- Francesca ScrofaniFrancesca Scrofani
- Raffaele FalsaperlaRFRaffaele Falsaperla
- Francesco PizzoFPFrancesco Pizzo
- Agata PolizziAPAgata Polizzi
- Antonio CorselloAntonio Corsello
- Maria Chiara ConsentinoMCMaria Chiara Consentino
- Enrico ParanoEPEnrico Parano
- Martino RuggieriMRMartino Ruggieri
Open Access
Abstract
Background/Objectives: Cutaneous hypopigmentation is a common clinical sign observed in a variety of disorders. It may be congenital or acquired, localized or diffuse, and can range from benign to being associated with systemic conditions, including those affecting the central nervous system. Recognition of the key clinical features associated with each disorder is essential for accurate diagnosis and for differentiating one condition from another. Methods: PubMed, Embase, and Scopus databases were used to prepare a systematic review. Search terms were: “congenital”, “cutaneous”, “localized”, “diffuse”, “hypopigmentation” and “neurological disorders/signs”. The focus was on congenital cutaneous hypopigmentation, distinguishing between localized and diffuse presentations, with emphasis on neurological involvement. Peer-reviewed articles, case series, and original studies with neurological manifestations of the disease were reviewed. Cutaneous hypopigmentation disorders associated with diffuse cerebral involvement include syndromes such as Chediak–Higashi, Griscelli, Elejalde, Cross, Tietz albinism-deafness, Prader–Willi, Angelman, and several congenital metabolic disorders. In contrast, the ‘localized’ group comprises syndromes such as Waardenburg, Incontinentia pigmenti, and the phacomatoses, including hypomelanosis of Ito and tuberous sclerosis complex. Results: Overlapping phenotypes and genetic heterogeneity lead to diagnostic challenges and potential errors suggesting multiple specialists. The main clinical features of each disorder are discussed, with particular attention paid to neurological signs. A practical flowchart is provided to help distinguish between ‘diffuse’ and ‘localized’ forms with neurological involvement. Conclusions: Early identification of cutaneous features, followed by comprehensive clinical and instrumental evaluation, enables timely and accurate diagnosis, ultimately improving the clinical outcomes for affected children.Keywords
This publication has 85 references indexed in Scilit:
- ATP7A‐related copper transport disorders: A systematic review and definition of the clinical subtypesJournal of Inherited Metabolic Disease, 2023
- Griscelli Syndrome in a seven years old girlClinical Case Reports, 2021
- Pulmonary manifestations in tuberous sclerosis complexAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2018
- Evaluating the frequency and characteristics of seizures in 142 Japanese patients with prader–willi syndromeAmerican Journal of Medical Genetics Part A, 2013
- Angelman syndrome associated with oculocutaneous albinism due to an intragenic deletion of the P geneAmerican Journal of Medical Genetics Part A, 2003
- Comment on Elejalde syndrome and relationship with Griscelli syndromeAmerican Journal of Medical Genetics Part A, 2002
- 12-year-old male with Elejalde syndrome (neuroectodermal melanolysosomal disease)American Journal of Medical Genetics, 2001
- Elejalde Syndrome—A Melanolysosomal Neurocutaneous SyndromeArchives of Dermatology, 1999
- Chédiak-Higashi SyndromeArchives of Neurology, 1984
- Mutations affecting pigmentation in man: I. Neuroectodermal melanolysosomal diseaseAmerican Journal of Medical Genetics, 1979